Evidence map›Paper›PMID 32154593›Full record

ArticleAlcoholism, clinical and experimental research2020

Targeting the Glucocorticoid Receptor Reduces Binge-Like Drinking in High Drinking in the Dark (HDID-1) Mice.

Antonia M Savarese, Angela R Ozburn, Pamela Metten, Jason P Schlumbohm, Wyatt R Hack, Kathryn LeMoine, Hazel Hunt, Felix Hausch, Michael Bauder, John C Crabbe

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 38 citations in OpenAlex.

  1. Drawbacks to Strengthening Neural Salience Encoding: A Link Between Cortisol and Risky Drinking.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Trial
  2. Review
  3. Central amygdalaNeurobiology of stress · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Retrieval of an Ethanol-Conditioned Taste Aversion Promotes GABAergic Plasticity in the Anterior Insular Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mifepristone decreases nicotine intake in dependent and non-dependent adult rats.Journal of psychopharmacology (Oxford, England) · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Antonia M SavareseDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0002-7899-2324
Angela R OzburnDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0002-8387-1156
Pamela MettenDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.
Jason P SchlumbohmDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.
Wyatt R HackDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.
Kathryn LeMoineDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.
Hazel HuntCorcept Therapeutics, Menlo Park, California.
Felix HauschInstitute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
Michael BauderInstitute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
John C CrabbeDepartment of Behavioral Neuroscience, Portland Alcohol Research Center, Oregon Health & Science University, Portland, Oregon.
Oregon Health & Science University · USTechnische Universität Darmstadt · DECorcept Therapeutics (United States) · US

Funding

Translational measures of risk for excessive alcohol consumptionP60AA010760 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAMARA J. PHILLIPS · 2006 to 2026
$34.5M
BIOLOGICAL BASES OF ALCOHOLISMT32AA007468 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Andrey E Ryabinin · 1987 to 2026
$11.3M
Selective Breeding for Drinking in the Circadian DarkU01AA013519 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Angela Renee Ozburn · 2001 to 2026
$10.9M
THERMAL AND METABOLIC DYSFUNCTION DURING WITHDRAWALP50AA010760 · NIAAA · OREGON HEALTH AND SCIENCE UNIVERSITY · PI CRABBE, JOHN C. · 1996 to 2005
$10.7M
Mouse Genetic Models for Alcohol ResearchR24AA020245 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI PHILLIPS, TAMARA J. · 2011 to 2020
$2.3M
Glucocorticoid Receptor Dysregulation: a Genetic Risk Factor for Excessive Alcohol Consumption in High Drinking in the Dark (HDID-1) MiceF32AA027692 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI SAVARESE, ANTONIA · 2019 to 2021
$151k
Pharmacogenetic manipulation of brain regions to reduce alcohol binge drinkingIK2BX002488 · VA · PORTLAND VA MEDICAL CENTER · PI OZBURN, ANGELA RENEE · 2015 to 2020
–
Genetic Models of AlcoholismI01BX000313 · VA · PORTLAND VA MEDICAL CENTER · PI CRABBE, JOHN C. · 2009 to 2019
–
BLRD VA I01 BX000313BLRD VA I01 BX004699BLRD VA IK2 BX002488NIAAA NIH HHS F32 AA027692NIAAA NIH HHS P50 AA010760NIAAA NIH HHS P60 AA010760NIAAA NIH HHS R24 AA020245NIAAA NIH HHS T32 AA007468NIAAA NIH HHS U01 AA013519
6 · The paper itself

Abstract

backgroundChronic alcohol exposure can alter glucocorticoid receptor (GR) function in some brain areas that promotes escalated and compulsive-like alcohol intake. GR antagonism can prevent dependence-induced escalation in drinking, but very little is known about the role of GR in regulating high-risk nondependent alcohol intake. Here, we investigate the role of GR in regulating binge-like drinking and aversive responses to alcohol in the High Drinking in the Dark (HDID-1) mice, which have been selectively bred for high blood ethanol (EtOH) concentrations (BECs) in the Drinking in the Dark (DID) test, and in their founder line, the HS/NPT.

methodsIn separate experiments, male and female HDID-1 mice were administered one of several compounds that inhibited GR or its negative regulator, FKBP51 (mifepristone [12.5, 25, 50, 100 mg/kg], CORT113176 [20, 40, 80 mg/kg], and SAFit2 [10, 20, 40 mg/kg]) during a 2-day DID task. EtOH consumption and BECs were measured. EtOH conditioned taste and place aversion (CTA and CPA, respectively) were measured in separate HDID-1 mice after mifepristone administration to assess GR's role in regulating the conditioned aversive effects of EtOH. Lastly, HS/NPT mice were administered CORT113176 during DID to assess whether dissimilar effects from those of HDID-1 would be observed, which could suggest that selective breeding had altered sensitivity to the effects of GR antagonism on binge-like drinking.

resultsGR antagonism (with both mifepristone and CORT113176) selectively reduced binge-like EtOH intake and BECs in the HDID-1 mice, while inhibition of FKBP51 did not alter intake or BECs. In contrast, GR antagonism had no effect on EtOH intake or BECs in the HS/NPT mice. Although HDID-1 mice exhibit attenuated EtOH CTA, mifepristone administration did not enhance the aversive effects of EtOH in either a CTA or CPA task.

conclusionThese data suggest that the selection process increased sensitivity to GR antagonism on EtOH intake in the HDID-1 mice, and support a role for the GR as a genetic risk factor for high-risk alcohol intake.

Indexed as

Alcohol DrinkingAnimalsAversive AgentsBinge DrinkingEthanolFemaleIsoquinolinesMaleMiceMifepristonePyrazolesReceptors, GlucocorticoidTacrolimus Binding Protein 5Tacrolimus Binding ProteinsAversive AgentsCORT113176EthanolIsoquinolinesMifepristonePyrazolesReceptors, GlucocorticoidTacrolimus Binding Protein 5Tacrolimus Binding ProteinsAlcoholAversionBinge DrinkingFKBP51Glucocorticoid Receptor

Identifiers

PMID32154593
PMCPMC7211124
OpenAlexW3011138838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.